Showing 934 results

Filters Content type: News, Editors' picks Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Access to healthcare

Stavudine, an HIV drug skeleton in India's closet

Editor's pick
Calcutta Telegraph
13 October 2011
Changing treatment

A fifth of patients discontinue Atripla within a year, CNS side-effects the main reason

News
19 September 2011
Neurological & cognitive problems

HIV Neuropathy Pain Patch Reaches for FDA Approval

Editor's pick
AIDSMeds
9 September 2011
Bone & joint problems

Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

News
19 July 2011
Bone & joint problems

Doubt remains if HIV therapy increases the risk of fragility fractures

News
18 July 2011
Side effects

European Medicines Agency plans public access to information on side effects

Editor's pick
European Medicines Agency
15 July 2011
Treatment guidelines

Abacavir matches tenofovir in Canadian patients with high viral load

News
13 July 2011
HIV treatment for children & young people

Anti-HIV drug Kaletra can cause adrenal problems in newborns

Editor's pick
Los Angeles Times
6 July 2011
Side effects

Global safety monitoring of HIV drugs is essential, says International Forum

Editor's pick
Eurekalert HIV
5 July 2011
Ageing & HIV

Some older HIV drugs linked to premature ageing

News
28 June 2011
Cardiovascular disease

Abacavir and cardiovascular risk: contradictory findings continue to emerge, mechanisms still unclear

News
22 June 2011
Side effects

Switch from efavirenz to raltegravir improves mood and lipid profiles

News
7 June 2011
New & experimental HIV treatments

Rilpivirine (Edurant) approved in United States

News
23 May 2011
Treatment guidelines

Some London clinics may have difficulty meeting drug prescription targets

News
20 April 2011
Starting treatment

High rate of liver fibrosis progression in HIV-positive patients, but signs that earlier initiation of antiretrovirals protective

News
18 April 2011
Kidney problems

Atazanavir associated with significant risk of kidney stones and renal impairment

News
14 April 2011
Cardiovascular disease

Large study shows that abacavir doesn't increase short or long-term risk of heart attack

News
8 April 2011
New & experimental HIV treatments

Once-daily nevirapine approved in United States

News
29 March 2011
Hepatitis C treatment

Reyataz May Be Safe for HIV-Positive People With Severe Liver Disease

Editor's pick
AIDSMeds
24 March 2011
Hepatitis C treatment

Copy of Reyataz May Be Safe for HIV-Positive People With Severe Liver Disease

Editor's pick
Kaiser Daily Global Health Policy Report
24 March 2011
Bone & joint problems

Fracture rates higher in patients with HIV

News
15 March 2011
Neurological & cognitive problems

Neuropathy still common in patients with HIV, older age a risk factor

News
14 March 2011
Child developmental issues

Adverse effects of ART use in pregnancy: prematurity continues to raise concerns

News
10 March 2011
Side effects

Feet first? Old mitochondria might be responsible for peripheral neuropathy

Editor's pick
EurekAlert
8 March 2011